Skip to main content
. 2014 Sep 3;11(10):3631–3641. doi: 10.1021/mp500364a

Figure 11.

Figure 11

Time-dependent antiproliferative assay of (a) irinotecan, (b) gemcitabine, (c) epirubicin, (d) dasatinib, (e) doxorubicin, (f) etoposide, (g) paclitaxel, (h) camptothecin, (i) fludarabine, and (j) clofarabine in the absence and presence of [W5R4C]–SeNPs. The experiments were conducted in triplicate (n = 3).